This site is intended for healthcare professionals only
LoginRegister
Cipla to buy 100 percent stake in Inzpera Healthsciences for Rs 110.65 croresCipla Bommasandra facility gets VAI classification from USFDA
Eli Lilly expands India presence with inauguration of Hyderabad siteEli Lilly expands India presence with inauguration of Hyderabad site
Novartis concludes acquisition of Tourmaline BioSetback To Novartis: CDSCO Panel Rejects Lanalumab Phase III Trial Design Over Study Flaws
Kerala Medical Services Corporation not procured rabies jabs without CDL certificate: NaddaKerala Medical Services Corporation not procured rabies vaccine without CDL certificate: Health...
NPPA Expands Ringer Lactate Price List, Adds Five Manufacturers and New Pack Types37 Essential Drugs Including Paracetamol, Atorvastatin To Get Cheaper, NPPA Issues Revised Price...
Cipla, Hetero win bid to supply widely prescribed diabetes drug in ChinaOver 5 lakh Tramadol, Alprazolam tablets worth Rs 20 crore seized,; 5 arrested
USFDA nod to Roche Gazyva/Gazyvaro for treatment of lupus nephritisRoche Susvimo maintains vision over five years with two refills per year in people with nAMD
Fire at MKCG Lab Prompts InspectionFire erupts at Dey's Medical plant in Kolkata, no injuries reported
Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMROne-shot Dengue vaccine 'DengiAll' completes 70% enrolment of participants in Phase III trial:...
Sun Pharma Gets CDSCO Panel Nod to Conduct Active Post-Marketing Study for Antacid Combination TabletSun Pharma Gets Relief As Delhi HC Bars Use of BERIVITAL, BEZOLIC, DOZE-30 For Trademark...
Sanores Pharma appoints Sanjay Moralwar as Head of ITSenores Pharma appoints Sanjay Moralwar as Head of IT
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in IndiaCDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in...
X